Actively Recruiting
Evaluating Valbenazine with Botulinum Toxin Injections for Treating Cervical Dystonia in Adults Aged 18 to 75
Led by Virginia Commonwealth University · Updated on 2026-06-04
20
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Adult-onset cervical dystonia CD is the most common form of idiopathic dystonia, affecting neck muscles and causing pain, limited movement, and disability. Current long-term treatments like botulinum toxin injections provide only partial relief and can have side effects, while deep brain stimulation is invasive and only moderately effective. This trial explores new treatment options to improve symptoms and quality of life for people with this chronic neurological condition. This study evaluates the safety and effectiveness of valbenazine, a dopamine-related medication, as an additional treatment alongside botulinum toxin injections for CD. Participants receive either placebo or valbenazine during their first 3-month injection cycle, then switch to the other treatment for the next 3 months. The trial uses a randomized, triple-blind design to compare valbenazine 80 mg daily with placebo in adults aged 18 to 75 who have ongoing symptoms despite stable botulinum toxin treatment. During the study, participants undergo assessments including the Toronto Western Spasmodic Torticollis Rating Scale TWSTRS to measure dystonia severity at baseline and after 12 weeks of treatment. Other evaluations include scales for anxiety, depression, sleep quality, and pain, conducted at baseline and mid-study visits. The research team monitors changes in motor symptoms, overall dystonia severity, and quality of life, with treatment lasting six months and ongoing safety checks throughout.
CONDITIONS
Brief Title
Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia
Research Team
A
Ananna Zaman
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here